Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
General Radiation Oncology
When do you offer adjuvant radiation therapy for a glomus tumor of uncertain malignant potential of the extremity resected with negative margins?
Related Questions
How do you manage intradural - extramedullary metastases of the spinal cord from non-CNS malignancies?
Has there been an observed interaction between ACE inhibitors and development of angioedema in a block demarcated superficial radiation therapy treatment volume (ex. lip)?
What is your approach to management of radiation-induced bullous pemphigoid?
Do patients with homocystinuria have an increase risk of radiation toxicity?
Would you re-irradiate a spleen with increasing splenomegaly for a patient with myelofibrosis?
What is the expected timeframe for the development of radiation myelitis and therapies that have helped with neurologic symptoms?
How do you manage a patient's pain from the skin tattoos placed at CT simulation?
With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?
When do you prefer to use bolus for treating superficial tumors adjacent to or involving the skin surface, especially for complex surface anatomy in the pelvis, head/neck, and extremity regions?
Are there any precautions you would take when radiating the pelvis in an obese patient with recent extensive ventral hernia repair to minimize dehiscence risk?
